Hotchkis & Wiley Capital Management
DBD

Hotchkis & Wiley Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,554,260
Closed -$5.8M – 564
2022
Q2 		$5.8M Buy
2,554,260
+1,560,780
+157% +$5.81M 0.02% 294
2022
Q1 		$6.69M Buy
993,480
+163,420
+20% +$1.4M 0.02% 295
2021
Q4 		$7.51M Buy
830,060
+412,220
+99% +$3.83M 0.02% 243
2021
Q3 		$4.22M Buy
417,840
+91,040
+28% +$999K 0.01% 380
2021
Q2 		$4.2M Buy
326,800
+34,240
+12% +$470K 0.01% 386
2021
Q1 		$4.13M Sell
292,560
-12,090
-4% -$166K 0.01% 364
2020
Q4 		$3.25M Buy
+304,650
New +$2.77M 0.01% 386

Other funds holding DBD

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $253M AUM 16.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.69B AUM 19.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return